Santos TY, Ramos CE, Trujillo AR, Gutiérrez MH, Martínez CYN, Ramírez FLC

Language: Spanish
References: 19
Page: 23-30
PDF size: 152.33 Kb.

ABSTRACT

The occurrence of cardiovascular events is 10 to 30 times higher in hemodialysis patients than in the general population and these are the leading cause of death. Based on this problem an observational, descriptive, longitudinal and prospective study was conducted to describe the cardiovascular complications in patients with chronic kidney disease who initiated hemodialysis during the period from January to December 2014 in the Department of Nephrology of “Arnaldo Milián Castro” Hospital; the population consisted of 63 patients with chronic kidney disease, stage V. It was concluded with a predominance of male patients, white skin and ages between 50 and 69 years; diabetic nephropathy was the most common cause of chronic kidney disease; cardiovascular complications in diabetic patients prevailed and during the procedure the hypotension and left ventricular dysfunction were the most frequent and cardiovascular mortality was the most prevalent.

REFERENCES

1. Gorostidi M, Santamaría R, Alcázarc R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, et al. Documento de la Sociedad Española de Nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica. Nefrología [Internet]. 2014 [citado 12 Abr 2015];34:302-16. Disponible en: http://www.revistanefrologia.com/es-publicacion-nefrologia-articulo-documento-sociedad-espanola-nefrologia-sobre-las-guias-kdigo-evaluacion-el-X0211699514054048

2. Allon M. Evidence-based cardiology in hemodialysis patients. J Am Soc Nephrol [Internet]. 2013 [citado 2 Mar 2014];24(12):1934-43. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24136920

3. Osterman M. Cardiac arrests in hemodiálisis patients: an engoing chayenge. Kidney Int. 2009;73:907-908.

4. Vlagopoulos PT, Sarnak MJ. Traditional and non-traditional cardiovascular risk factors in chronic kidney disease. Med Clin North Am. 2005;89:587-611.

5. Stevinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol. 2003;14:1927-1939.

6. Atiés Sánchez MC, Collado Nieto S, Pascual Santos J, Cao H, Barbosa F. Factores de riesgo y complicaciones cardiovasculares en pacientes con enfermedad renal crónica en hemodiálisis: prevalencia, morbilidad y mortalidad. Rev Cubana Invest Bioméd [Internet]. 2012 [citado 12 Abr 2014];31(2):214-225. Disponible en: http://scielo.sld.cu/pdf/ibi/v31n2/ibi08212.pdf

7. Berl T, Heinrich W. Kidney-heart interactions: epidemiology, pathogenesis and treatment. Clin J Am Soc Nephrol. 2006;1:8-18.

8. Fariña Peláez RA. Mortalidad en hemodiálisis, factores asociados [tesis]. Santa Clara: Hospital Clínico Quirúrgico “Arnaldo Milián Castro”; 2010.

9. Hillege HL, Van Gilst WH, Van Veldhuisen DJ, Navis G, Grobbee DE, De Graeff PA, et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J. 2003; 24:412-20.

10. Arencibia Pita L, Rodríguez López L, Arencibia Echeverría FA, Serrano Morillo A, De la Cruz Moreno S. Factores de riesgo y complicaciones cardiovasculares en los pacientes en diálisis peritoneal. Rev Cub Med Int Emerg [Internet]. 2004 [citado 7 Jul 2013];3(4):73-80. Disponible en: http://bvs.sld.cu/revistas/mie/vol3_4_04/mie07404.pdf

11. Valdés S, Rojo Martínez G, Soriguer F. Evolución de la prevalencia de la diabetes tipo 2 en población adulta española. Med Clin (Barc) [Internet]. 2007 [citado 12 Abr 2014];129(9):352-5. Disponible en: http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13109554&pident_usuario=0&pcontactid=&pident_revista=2&ty=10&accion=L&origen=zonadelectura&web=www.elsevier.es&lan=es&fichero=2v129n09a13109554pdf001.pdf

12. Sociedad Española de Nefrología. Informe de diálisis y trasplante 2010. XL Congreso Nacional de la SEN. Sevilla, 14-17 octubre; 2011.

13. Coli L, Ursino M, Donati G, Cianciolo G. Clinical application of sodium profiling in the treatment of intradialytic hypotension. Int J Artif Organs. 2003;26(8):715-22.

14. Gorriz JL, Martinez-Castelao A, De Alvaro F, Cases A, Portoles J, Luño J, et al. Morbidity and mortality factors in chronic kidney disease: diabetic and non-diabetic patients (MERENA study): baseline data. Nephrol Dial Transplant. 2005;20:17.

15. Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, Pannu N, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet [Internet]. 2012 [citado 21 Nov 2015];380(9844):807-814. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22717317

16. Bataille S, Brunet P, Decourt A, Bonnet G, Loundou A, Berland Y, et al. Pericarditis in uremic patients: serum albumin and size of pericardial effusion predict drainage necessity. J Nephrol [Internet]. 2015 [citado 22 Oct 2015];28(1):97-104. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/24840780

17. Collado Nieto S, Coll E, Deulofeu R, Guerrero L, Pons M, Cruzado JM, et al Prevalencia de enfermedad cardiovascular en la uremia y relevancia de los factores de riesgo cardiovascular. Nefrología (Madr.) [Internet]. 2010 [citado 25 Abr 2014];30(3):[aprox. 10 p.]. Disponible en: http://scielo.isciii.es/scielo.php?pid=S0211-69952010000300012&script=sci_arttext

18. Chanda J, Fenves AZ. Hypertension in patients with chronic kidney disease. Curr Hypertens Rep [Internet]. 2009 [citado 12 Abr 2014];11(5):329-36. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19737449

19. Chávez-López EL, Alemán-Ortiz OF, Nando-Villicaña CC, Rosas-Munive E. Síndrome cardiorrenal: nuevas perspectivas. Rev Mex Cardiol [Internet]. 2015 [citado 12 Abr 2014];26(1):[aprox. 21 p]. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0188-21982015000100006